Patent Assignment
Reel/Frame 057438/0014
Change of Name
Recorded: 2021-09-08
Pages: 4
Assignor
IMMUNITYBIO, INC.
Executed: 2021-03-09
Assignee
NANTCELL, INC.
9920 JEFFERSON BLVD., CULVER CITY, CALIFORNIA, 90232
Covered Property
(1)
Anti Covid-19 Therapies Using CD40 Ligand Fusion Protein
Application:
17/082,994 →
Publication:
US 2021/0284713
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.